Pharmaceutical Development Executive Jeffrey Kasher, Ph.D., Joins DrugDev As Chairman Of Advisory Board

KING OF PRUSSIA, Pa. & LONDON--(BUSINESS WIRE)--DrugDev continues to attract pharmaceutical industry visionaries to join its mission of developing innovative clinical technology solutions to help sponsors, CROs and sites do more trials together. Today, the company announced Jeffrey Kasher, Ph.D., has joined as Chairman of the DrugDev Advisory Board, a distinguished team of current and former clinical research executives from many of the leading pharmaceutical companies in the world.